{"symbol":"PFE","fiscalQuarter":"Q3-2021","reportDate":"2021-11-02","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q3-2021","postBrief":{"headline":"Pfizer Beats on EPS, Stock Up 4.15%","keyNumbers":[{"metric":"EPS","actual":"$1.42","expected":"N/A","surprise":"+31.24%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on delivering value through our ongoing projects."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to ongoing projects. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's strong EPS performance of $1.42, significantly above expectations, led to a positive stock reaction, with shares rising 4.15%. The company did not disclose revenue figures or future guidance, which leaves some uncertainty. Overall, the earnings report reflects Pfizer's solid performance in a competitive environment.","metaDescription":"Pfizer Inc (PFE) Q3 2021 earnings: EPS beat expectations. Stock up 4.15%. Full breakdown."}}